retinal neovascular disease
Conditions
Interventions
wet age related macular degeneration group:Intravitreal injection of Conbercept
proliferative diabetic retinopathy group:Intravitreal injection of Conbercept
retinal vein occlusion group:Intravitreal injection of Conbercept
Sponsors
Jingliang Eye Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) participants of wet age-related macular degeneration, proliferative diabetic retinopathy or retinal vein occlusion; (2) the fundus examination shows neovascularization and / or macular edema, meet the indication of anti-VEGF treatment; (3) participants are willing and able to receive anti-VEGF agent (Conbercept).
Exclusion criteria
Exclusion criteria: (1) participants suffering from severe systemic diseases at the same time; (2) fundus examinations could not be performed due to vitreous hemorrhage, retinal detachment or other disorders; (3) participants intolerant or not fit for treatment because of other conditions;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| best corrected visual acuity;foveal avascular zone area;retinal foveal thickness;retinal vascular density; | — |
Secondary
| Measure | Time frame |
|---|---|
| choroidal thickness;Intraocular pressure;retinal thickness; | — |
Countries
China
Contacts
Public ContactQiuming Hu
Guangxi University of Chinese Medicine
Outcome results
None listed